As of May 27
| -0.0075 / -0.78%|
The 1 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +31.15% increase from the last price of 0.95.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.